aTyr Pharma reported $2.44M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
Ardelyx USD 120.88M 26.41M Jun/2026
aTyr Pharma USD 2.44M 151K Jun/2026
Biogen USD 2.8B 60M Sep/2026
Bristol-Myers Squibb USD 13.07B 100M Sep/2026
Cipla INR 74.04B 2.85B Sep/2026
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 2.6M 3.75M Jun/2026
CSL USD 8.33B 4.79B Dec/2025
Curis USD 1.14M 1.41M Dec/2025
GlaxoSmithKline GBP 8.89B 480M Sep/2026
Grifols EUR 2B 306.7M Mar/2026
Lakefront Biotherapeutics EUR 7.11M 5M Sep/2026
Novartis USD 14.52B 112M Sep/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
United Therapeutics USD 832.5M 49.2M Sep/2026